BR112013027489A2 - uso de ?-polilisina (épsilon-polilisina) - Google Patents

uso de ?-polilisina (épsilon-polilisina)

Info

Publication number
BR112013027489A2
BR112013027489A2 BR112013027489A BR112013027489A BR112013027489A2 BR 112013027489 A2 BR112013027489 A2 BR 112013027489A2 BR 112013027489 A BR112013027489 A BR 112013027489A BR 112013027489 A BR112013027489 A BR 112013027489A BR 112013027489 A2 BR112013027489 A2 BR 112013027489A2
Authority
BR
Brazil
Prior art keywords
polylysine
epsilon
induction
human skin
antimicrobial peptides
Prior art date
Application number
BR112013027489A
Other languages
English (en)
Other versions
BR112013027489B1 (pt
Inventor
Lorenz Janina
Thiesen Kathrin
Terstegen Lara
Braren Sandra
Original Assignee
Beiersdorf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf Ag filed Critical Beiersdorf Ag
Publication of BR112013027489A2 publication Critical patent/BR112013027489A2/pt
Publication of BR112013027489B1 publication Critical patent/BR112013027489B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Polyamides (AREA)

Abstract

resumo uso de e-polilisina (épsilon-polilisina) uso de e-polilisina (épsilon-polilisina) para a indução de peptídeos antimicrobianos na pele humana.
BR112013027489-1A 2011-06-07 2012-05-18 uso cosmético de e-polilisina (épsilon-polilisina) BR112013027489B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102011077052A DE102011077052A1 (de) 2011-06-07 2011-06-07 Verwendung von epsilon-Poly-L-Lysin zur Erhöhung der Bioverfügbarkeit antimikrobieller Peptide in menschlicher Haut.
PCT/EP2012/059235 WO2012168050A1 (de) 2011-06-07 2012-05-18 Verwendung von epsilon-poly-l-lysin zur erhöhung der bioverfügbarkeit antimikrobieller peptide in menschlicher haut

Publications (2)

Publication Number Publication Date
BR112013027489A2 true BR112013027489A2 (pt) 2017-02-14
BR112013027489B1 BR112013027489B1 (pt) 2019-10-29

Family

ID=46168434

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013027489-1A BR112013027489B1 (pt) 2011-06-07 2012-05-18 uso cosmético de e-polilisina (épsilon-polilisina)

Country Status (4)

Country Link
EP (1) EP2717965B1 (pt)
BR (1) BR112013027489B1 (pt)
DE (1) DE102011077052A1 (pt)
WO (1) WO2012168050A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201409451D0 (en) 2014-05-28 2014-07-09 Ipabc Ltd Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms
KR102285956B1 (ko) * 2018-11-26 2021-08-04 한국해양과학기술원 지방 생성을 자극하는 펩타이드, 조성 및 방법
US20240000690A1 (en) * 2020-12-07 2024-01-04 Conopco, Inc., D/B/A Unilever Antiperspirant compositions
US11931458B2 (en) 2021-01-11 2024-03-19 Babak Ghalili Exosome systems, products and methods
US20220226242A1 (en) * 2021-01-11 2022-07-21 Babak Ghalili Exosome systems, products and methods

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001068085A1 (en) 2000-03-15 2001-09-20 Genaera Corporation A method for stimulation of defensin production
WO2002006821A2 (en) 2000-07-17 2002-01-24 Hansa Medical Ab Antimicrobial agent
US7041506B2 (en) * 2001-11-19 2006-05-09 Becton Dickinson And Company Peptides promoting cell adherence, growth and secretion
JP2003171464A (ja) * 2001-12-06 2003-06-20 Chisso Corp ポリリジン及びその製造方法
JP2004067587A (ja) * 2002-08-06 2004-03-04 Chisso Corp 化粧料
FR2863893B1 (fr) 2005-02-02 2008-04-18 Coletica Utilisation de principes actifs stimulant les beta-defensines humaines de type 2 et/ou de type 3
DE102005014687A1 (de) 2005-03-29 2006-10-12 Henkel Kgaa Zusammensetzung enthaltend ß-Defensin 2
FR2896691B1 (fr) 2006-02-02 2008-06-13 Fabre Pierre Dermo Cosmetique Utilisation d'esters d'alkylglucoside comme inducteurs de beta-defensines
FR2914189A1 (fr) 2007-03-26 2008-10-03 Oreal Utilisation d'une fraction lipopolysaccharidique de vitreoscilla filiformis comme agent stimulant la synthese de peptides antimicrobiens de la peau.
FR2916634B1 (fr) 2007-06-01 2009-10-02 Jean Noel Thorel Association synergique vis-a-vis de la flore microbienne de l'epiderme humain et applications cosmetiques et pharmaceutiques
DE102007044093A1 (de) 2007-09-14 2009-03-19 Phenion Gmbh & Co. Kg Nukleinsäurehaltige kosmetische und/oder pharmazeutische Zubereitungen zur Induktion antimikrobieller Peptide in epithelialen Deckgeweben
DE102009029110A1 (de) 2009-09-02 2011-03-03 Henkel Ag & Co. Kgaa Antimikrobielle Formulierung

Also Published As

Publication number Publication date
DE102011077052A1 (de) 2012-12-13
BR112013027489B1 (pt) 2019-10-29
WO2012168050A1 (de) 2012-12-13
EP2717965B1 (de) 2017-11-01
EP2717965A1 (de) 2014-04-16

Similar Documents

Publication Publication Date Title
UY34782A (es) Anticuerpos humanos para fel d1 y métodos para usarlos.
MY167585A (en) Disposable diaper
SG11201402178VA (en) Beauty instrument
CO6930321A2 (es) Curación de tejidos
CL2012003385A1 (es) Tratamiento para la incontinencia.
BR112013025742A2 (pt) composição de vidros bioativos, sua utilização e respectivo métodos de obtenção.
BR112013029773A2 (pt) canabinoides para uso no tratamento de dor neuropática
BR112013027218A2 (pt) prótese endovascular e dispositivo de distribuição
AU342489S (en) Circular stapler
MY167655A (en) Absorbent article
ZA201307641B (en) Human tissue factor antibody and uses thereof
MY167663A (en) Absorbent article
BR112014006419A2 (pt) métodos para tratar um paciente com câncer, kit e artigo
IN2014DN11201A (pt)
BR112014016240A2 (pt) dispositivo para tratamento de pele
BR112015007861A2 (pt) prótese de tecido
MY167652A (en) Disposable diaper
MY166103A (en) Disposable diaper
IL262977B (en) Identification of human antibodies in cell-specificity
AU339402S (en) Epilator
HK1173512A1 (en) Highly integrated low-power reference source
BR112014005279A2 (pt) máquina para fazer artigos de higiene absorventes
BR112013027489A2 (pt) uso de ?-polilisina (épsilon-polilisina)
BR112013023144A2 (pt) método de tratamento de couro cabeludo
PL2670490T3 (pl) Dezodorujący film tworzący się na skórze

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/05/2012, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/05/2012, OBSERVADAS AS CONDICOES LEGAIS

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 11A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2724 DE 21-03-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.